Adlai Nortye (NASDAQ: ANL) has recently received a number of price target changes and ratings updates:
- 9/10/2026 – Adlai Nortye is now covered by Jefferies Financial Group Inc.. They set a “buy” rating and a $31.00 price target on the stock.
- 9/8/2026 – Adlai Nortye was given a new $49.00 price target by Loop Capital.
- 9/8/2026 – Adlai Nortye had its “buy” rating reaffirmed by HC Wainwright. They now have a $20.00 price target on the stock.
- 8/22/2026 – Adlai Nortye was upgraded by Wall Street Zen from “hold” to “buy”.
- 7/14/2026 – Adlai Nortye had its “sell (e+)” rating reaffirmed by Weiss Ratings.
Insider Buying and Selling at Adlai Nortye
In other news, CFO Xiaofeng Ye sold 6,000 shares of the company’s stock in a transaction that occurred on Monday, August 24th. The shares were sold at an average price of $13.98, for a total transaction of $83,880.00. Following the transaction, the chief financial officer directly owned 153,424 shares in the company, valued at approximately $2,144,867.52. This represents a 3.76% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Adlai Nortye’s product portfolio includes betaine compounds, a range of high-purity L-amino acids such as L-methionine, L-threonine and glycine, as well as various chemical intermediates. These offerings serve multiple end markets, including animal feed and nutrition, personal care and cosmetic formulations, pharmaceutical ingredients and industrial chemical processes.
The company operates multiple production facilities alongside an in-house research and development center dedicated to process innovation and quality control.
Featured Stories
- Five stocks we like better than Adlai Nortye
- GameStop’s Comeback Case Is Getting Interesting, But eBay Still Looks Stronger
- Why Braze’s Guidance Miss May Be a Gift for Investors
- This Corner of the Market Is Outperforming the Benchmark—And It’s Not AI
- Victoria’s Secret’s Comeback Is Real—The Stock’s Problem Is Different
Receive News & Ratings for Adlai Nortye Ltd Sponsored ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adlai Nortye Ltd Sponsored ADR and related companies with MarketBeat.com's FREE daily email newsletter.
